Evidence map›Paper›PMID 27770024›Full record

ArticleThe Journal of biological chemistry2016

Structural and Biochemical Characterization of Spa47 Provides Mechanistic Insight into Type III Secretion System ATPase Activation and Shigella Virulence Regulation.

Jamie L Burgess, R Alan Burgess, Yalemi Morales, Jenna M Bouvang, Sean J Johnson, Nicholas E Dickenson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Differential regulation ofFrontiers in cellular and infection microbiology · 2023
    Article
  4. Article
  5. Article
  6. TheMicroorganisms · 2021
    Review
  7. Composition and Biophysical Properties of the Sorting Platform Pods in theFrontiers in cellular and infection microbiology · 2021
    Article
  8. The T3SS ofMicroorganisms · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jamie L BurgessFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322.
R Alan BurgessFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322.
Yalemi MoralesFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322.
Jenna M BouvangFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322.
Sean J JohnsonFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322.
Nicholas E DickensonFrom the Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322 nick.dickenson@usu.edu.
Utah State University · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Mechanisms of Type III Secretion System ATPase Activation and RegulationR15AI124108 · NIAID · UTAH STATE UNIVERSITY · PI DICKENSON, NICHOLAS E · 2017 to 2020
$832k
Lipid raft effects on Shigella type III secretion system-based interactionsK22AI099086 · NIAID · UTAH STATE UNIVERSITY · PI DICKENSON, NICHOLAS E · 2013 to 2014
$268k
NIAID NIH HHS K22 AI099086NIGMS NIH HHS P41 GM103393
6 · The paper itself

Abstract

Like many Gram-negative pathogens, Shigella rely on a complex type III secretion system (T3SS) to inject effector proteins into host cells, take over host functions, and ultimately establish infection. Despite these critical roles, the energetics and regulatory mechanisms controlling the T3SS and pathogen virulence remain largely unclear. In this study, we present a series of high resolution crystal structures of Spa47 and use the structures to model an activated Spa47 oligomer, finding that ATP hydrolysis may be supported by specific side chain contributions from adjacent protomers within the complex. Follow-up mutagenesis experiments targeting the predicted active site residues validate the oligomeric model and determined that each of the tested residues are essential for Spa47 ATPase activity, although they are not directly responsible for stable oligomer formation. Although N-terminal domain truncation was necessary for crystal formation, it resulted in strictly monomeric Spa47 that is unable to hydrolyze ATP, despite maintaining the canonical ATPase core structure and active site residues. Coupled with studies of ATPase inactive full-length Spa47 point mutants, we find that Spa47 oligomerization and ATP hydrolysis are needed for complete T3SS apparatus formation, a proper translocator secretion profile, and Shigella virulence. This work represents the first structure-function characterization of Spa47, uniquely complementing the multitude of included Shigella T3SS phenotype assays and providing a more complete understanding of T3SS ATPase-mediated pathogen virulence. Additionally, these findings provide a strong platform for follow-up studies evaluating regulation of Spa47 oligomerization in vivo as a much needed means of treating and perhaps preventing shigellosis.

Indexed as

Point MutationProtein MultimerizationAdenosine TriphosphatasesBacterial Secretion SystemsHumansShigella flexneriStructure-Activity RelationshipAdenosine TriphosphatasesBacterial Secretion SystemsSpa47 protein, Shigella flexneriarginine fingerATPasecrystal structureoligomerizationsecretion regulationShigellaSpa47type III secretion apparatus (T3SA)type III secretion system (T3SS)

Identifiers

PMID27770024
PMCPMC5207059
OpenAlexW2534888867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.